NCT00086645View on ClinicalTrials.gov

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

April 30, 2007

Conditions
Autistic Disorder
Interventions
DRUG

citalopram hydrobromide

10mg/5ml solution

OTHER

placebo

up to equivalent of 20 mg of active comparator daily

Trial Locations (6)

10029

Mount Sinai School of Medicine, New York

11021

North Shore - Long Island Jewish Hospital, Great Neck

25714

University of North Carolina Chapel Hill, Chapel Hill

90024

UCLA Neuropsychiatric Institute, Los Angeles

06510

Yale University, New Haven

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Boston University

OTHER

NCT00086645 - Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) | Biotech Hunter | Biotech Hunter